Sangers Sequencing Service Market Value Expected to Show $1,085 Million by 2025

"Sangers sequencing service market for biomarker and cancer application is projected to exhibit significant growth in the near future, owing to increase in scope of research in oncology & biomarker discovery and surge in prevalence of chronic diseases such as, cancer."

According to a new report published by Allied Market Research, titled, "sanger's Sequencing Service Market by Application and End User: Global Opportunity Analysis and Industry Forecast, 2013-2025.The global sanger's sequencing service market was valued at $192 million in 2013, and is projected to reach $1,085 million by 2025, at a CAGR of 14.2% from 2018 to 2025. The growth of the market is driven by factors such as increase in the usage and applications of sanger's sequencing, especially in oncology research, diagnostics, reproductive health, and others. Furthermore, the market for sanger's sequencing services has witnessed tremendous growth in the recent years, due to upsurge in demand for this technique in genomics, transcriptomics, and other life science-related research areas.

Send Enquiry on this report @ https://www.alliedmarketresearch.com/purchase-enquiry/4611

The key drivers of the global sanger's sequencing service market are surge in technological advancements, especially microfluidic sanger's sequencing and rise in the number of collaborations & partnerships to promote the use of DNA sequencing in hospitals & research centers. In addition, heavy inflow of investment in R&D activities has facilitated the propagation of sanger's sequencing services, thereby providing lucrative opportunities for the market players. However, concerns related to accuracy & standardization and dearth of skilled professionals hamper the market growth.

sanger's sequencing has the potential to precisely differentiate between the genetic variations and facilitate the generation of potent biomarkers for medicine and disease diagnosis. In addition, low sequencing time, concise protocol length, and rise in cost of sequencing have increased its usage in biomarker discovery and cancer. The global biomarker & cancer sanger's sequencing service market is expected to reach $390 million by 2025.

Among the different end users, academic & government research institutes nearly occupied one-third share in the global sanger's sequencing service market in 2013. This is attributed to the fact that sanger's sequencing services have the capability to provide precise genomic information without the high costs associated with other methods of sequencing.

The United States was the leading revenue contributor to the global market in 2013, occupying nearly half of the total market share owing to high adoption rate of technologically advanced Sanger sequencing services. However, China is expected to grow at the highest CAGR of 17.2% from 2018 to 2025, owing to increase in disposable income; surge in research, development, & innovation activities; and growth in awareness of sanger's sequencing.

Get Access to TOC / Sample Report @ https://www.alliedmarketresearch.com/request-sample/4611

Key Findings of the sanger's Sequencing Service Market:

• EU accounted for more than one-third of the share of the sanger's sequencing service market in 2013.
• The personalized medicine application segment is anticipated to grow with the highest CAGR throughout the forecast period.
• Academic and government research institutes accounted for nearly one-third of the global sanger's sequencing service market in 2013.
• China is anticipated to grow at the highest rate in the market during the analysis period.

The report provides extensive competitive analysis and profiles of key market players such as Source BioScience, GenScript Biotech Corporation, Thermo Fisher Scientific, Inc., LGC Science Group Limited, Fasteris SA, CeMIA SA, Quintara Biosciences, GenHunter Corporation, GENEWIZ, Nucleics, SciGenom Labs Pvt. Limited, and Microsynth AG. Inc. The other players in the value chain (not included in the report) include Laragen, Inc. and StarSEQ GmbH.

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.